Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Theranostic biomarkers in hypertrophic cardiomyopathy: insights in a long road ahead.

Frontiers in bioscience (Landmark edition) - 1 Jun 2017

Sartorio Carmem L, Lazzeroni Davide, Bertoli Gloria, Camici Paolo G

Abstract excerpt

The study of biomarkers and their related signalling pathways has allowed the development of new therapeutic strategies in a range of disorders. However, in hypertrophic cardiomyopathy (HCM), which is the most common hereditary cardiac disease, there are many potential biomarkers described, but their specificity and applicability for HCM remains an open field. The aim of the present review is to provide an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Cardiomyopathy, Hypertrophic
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenesis, Genetic

Share to Histones

Share to MicroRNAs

Share to Mutation

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 28410142
DOI: 10.2741/4568

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Theranostic biomarkers in hypertrophic cardiomyopathy: insights in a long road ahead.PMID 28410142Read ↗

Hypertrophic cardiomyopathy: current understanding and treatment objectives.Semantic proximity Read ↗

Genetics of hypertrophic cardiomyopathy: advances and pitfalls in molecular diagnosis and therapySemantic proximity Read ↗

Hypertrophic cardiomyopathy: an up-to-date snapshot of the clinical drug development pipeline.Semantic proximity Read ↗

Hypertrophic cardiomyopathy: pathological features and molecular pathogenesis.Semantic proximity Read ↗

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.Semantic proximity Read ↗

Genetic basis of hypertrophic cardiomyopathy.Semantic proximity Read ↗

Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy.Semantic proximity Read ↗

MicroRNAs in hypertrophic cardiomyopathy: pathogenesis, diagnosis, treatment potential and roles as clinical biomarkersSemantic proximity Read ↗

Risk stratification in hypertrophic cardiomyopathy: time for renewal?Semantic proximity Read ↗

Hypertrophic cardiomyopathy--state of the art in 2007.Semantic proximity Read ↗

Genetic biomarkers in hypertrophic cardiomyopathy.Semantic proximity Read ↗

[Hypertrophic cardiomyopathy].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.